Alice Renard

Alice Renard

Partner

Alice is a Partner of Syncona Investment Management Ltd.

She is also currently Head of Operations at Purespring Therapeutics and works closely with Anaveon. Alice serves as an Observer on the Board of Purespring and Anaveon.

Prior to joining Syncona, Alice was an Investment Banking Analyst within Barclays’ Healthcare Corporate Finance and M&A team, where she worked on transactions involving pharmaceutical and other healthcare companies. Prior to Barclays, Alice worked briefly at AbbVie and Janssen. Alice holds a Doctorate degree in Pharmacy from the University of Lille 2 (School of Pharmacy, Lille, France). She holds a Masters in International Health Policy & Health Economics from the London School of Economics.

Syncona portfolio companies

  • Anaveon (Board observer)
  • Purespring Therapeutics
Martin Murphy

Martin Murphy

Chief Executive Officer
Chris Hollowood

Chris Hollowood

Chief Investment Officer
Markus John

Markus John

Chief Medical Officer and Head of R&D
Freddie Dear

Freddie Dear

Partner
Kenneth Galbraith

Kenneth Galbraith

Executive in Residence
Elisa Petris

Elisa Petris

Partner